Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
39.42
-0.03 (-0.08%)
At close: Sep 12, 2025, 4:00 PM EDT
39.75
+0.33 (0.84%)
After-hours: Sep 12, 2025, 6:03 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Branded
116.12M
Log In
Log In
Log In
Log In
Upgrade
ImprimisRx
83.50M
Log In
Log In
Log In
Log In
Upgrade
Innovative Ophthalmic Therapies
-
Log In
Log In
Log In
Log In
Upgrade
Innovative Ophthalmic Therapies Growth
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Compounding
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Compounding Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
199.61M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
53.32%
Log In
Log In
Log In
Log In
Upgrade